NCT04147936 - Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 30, 2019

Primary Completion Date

May 20, 2020

Study Completion Date

June 24, 2020

Conditions

Hepatic Insufficiency

Interventions

DIETARY_SUPPLEMENT

AXA1665

Dietary supplement: AXA1665

DIETARY_SUPPLEMENT

Placebo

Trial Locations (11)

UPMC Center for Liver Disease, Pittsburgh

Virginia Commonwealth University, Richmond

Atlanta Center for Medical Research, Atlanta

OMEGA Research Maitland, LCC, Orlando

Panax Clinical Research, Miami Lakes

Avita Clinical Research, Tampa

Indiana University Health, Indianapolis

Delta Research Partners, Bastrop

Texas Liver Institute, San Antonio

Catalina Research Institute, LLC, Montclair

Orange County Research Center, Tustin